Abstract
Lung adenocarcinoma, the most common subtype of lung cancer, is the leading cause of cancer death worldwide. Despite attempts for the treatment of lung cancer which have been accumulating, promising new therapies are still needed. Here, we found that cyclic-AMP response element-binding protein (CREB)-CREB binding protein (CBP) transcription factors complex inhibitor, Naphthol AS-TR phosphate (NASTRp), is a potential therapeutic agent for lung cancer. We show that NASTRp inhibited oncogenic cell properties through cell cycle arrest with concomitant suppression of tumor-promoting autophagy with down-regulations of Atg5-12 and Atg7, and accumulation of p62 in human lung cancer cell lines. In addition, NASTRp induced expression of endoplasmic reticulum stress markers such as DDIT3/CHOP, and led to apoptosis along with Bim induction. These findings suggest that transcription factor/co-activator complex, CREB-CBP, can be a potential therapeutic target and its inhibition could be a novel therapeutic strategy for lung cancer.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adenocarcinoma / metabolism
-
Adenocarcinoma / mortality
-
Adenocarcinoma / pathology
-
Adenocarcinoma of Lung
-
Anilides / chemistry
-
Anilides / pharmacology*
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / pharmacology*
-
Apoptosis Regulatory Proteins / metabolism
-
Autophagy
-
Autophagy-Related Protein 7
-
Bcl-2-Like Protein 11
-
Cell Cycle Checkpoints
-
Cell Line, Tumor
-
Cyclic AMP Response Element-Binding Protein / antagonists & inhibitors*
-
Cyclic AMP Response Element-Binding Protein / chemistry
-
Drug Screening Assays, Antitumor
-
Endoplasmic Reticulum Stress
-
Humans
-
Inhibitory Concentration 50
-
Kaplan-Meier Estimate
-
Lung Neoplasms / metabolism
-
Lung Neoplasms / mortality
-
Lung Neoplasms / pathology
-
Membrane Proteins / metabolism
-
Molecular Docking Simulation
-
Organophosphates / chemistry
-
Organophosphates / pharmacology*
-
Peptide Fragments / antagonists & inhibitors*
-
Peptide Fragments / chemistry
-
Proportional Hazards Models
-
Protein Binding
-
Proto-Oncogene Proteins / metabolism
-
Sialoglycoproteins / antagonists & inhibitors*
-
Sialoglycoproteins / chemistry
-
Ubiquitin-Activating Enzymes / metabolism
Substances
-
Anilides
-
Antineoplastic Agents
-
Apoptosis Regulatory Proteins
-
BCL2L11 protein, human
-
Bcl-2-Like Protein 11
-
CREB1 protein, human
-
Cyclic AMP Response Element-Binding Protein
-
Membrane Proteins
-
Organophosphates
-
Peptide Fragments
-
Proto-Oncogene Proteins
-
Sialoglycoproteins
-
bone sialoprotein (35-62), human
-
naphthol AS-TR phosphate
-
ATG7 protein, human
-
Autophagy-Related Protein 7
-
Ubiquitin-Activating Enzymes